Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 2Phase 1 2Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 18CNS 8Genitourinary 6Gastrointestinal 6Other solid neoplasm 3Dermatologic 3Thoracic 2Gynecologic 2Lymphoid 1Head & Neck 1

Conditions

Ovarian Neoplasms 673Breast Neoplasms 265Uterine Cervical Neoplasms 239Carcinoma, Non-Small-Cell Lung 217Endometrial Neoplasms 200Fallopian Tube Neoplasms 187Carcinoma, Ovarian Epithelial 175Colorectal Neoplasms 163Stomach Neoplasms 151Pancreatic Neoplasms 144Neoplasms 143Melanoma 118Lung Neoplasms 112Carcinoma, Renal Cell 110Prostatic Neoplasms 108Triple Negative Breast Neoplasms 107Squamous Cell Carcinoma of Head and Neck 97Neoplasm Metastasis 96Esophageal Neoplasms 89Urinary Bladder Neoplasms 85Head and Neck Neoplasms 82Sarcoma 69Small Cell Lung Carcinoma 63Carcinoma, Hepatocellular 63Colonic Neoplasms 56Carcinoma, Transitional Cell 48Kidney Neoplasms 41Testicular Neoplasms 38Peritoneal Neoplasms 37Anus Neoplasms 34

Interventions

selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Neurofibrosarcoma × Gynecologic × Clear all
NCT07244835 2026-05-13

A Study of DEG6498 in Participants With Solid Tumors

Degron Therapeutics Co.

Phase 1 Recruiting
100 enrolled
CNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Glioblastoma, Carcinoma, Hepatocellular, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Neurofibrosarcoma

NCT04811196 2025-05-29

A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients

University Health Network, Toronto

Phase 1 Completed
56 enrolled
GynecologicSarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Endometrial Stromal, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡